<div class="p4l_caption"><div class="p4l_captionTitle"><a target="_blank" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4405777/" ref="ordinalpos=4456&amp;ncbi_uid=7448074&amp;link_uid=PMC4405777" image-link="/pmc/articles/PMC4405777/figure/F2/" class="imagepopup">Figure 2.  From: A potent combination of the novel PI3K inhibitor, GDC-0941, with imatinib in gastrointestinal stromal tumor xenografts: long-lasting responses after treatment withdrawal. </a></div><br /><div class="p4l_captionBody">Densitometric assessment of active (phospho-) protein forms in KIT signaling pathway.</div></div>